Moreover, MMSET interacts with NF-κB directly to activate the expression of NF-κB target genes (including interleukin-6, vascular endothelial growth factor A, cyclin D, Bcl-2 and Survivin) in prostate cancer cells [19]. This evidence concerns the gene IL6 and Familial prostate cancer.